ERBB2 and esophageal cancer: YAP has been shown to be able to transcriptionally upregulate EGFR in esophageal cancer tissues through TEAD binding sites47; in ErbB2/EGFR-transgenic mice, increased YAP level in nuclei of mammary glands was observed48.